FDA says "yes" to Boston extending Taxus shelf life
This article was originally published in Clinica
Executive Summary
Boston Scientific's Taxus Express2 paclitaxel-eluting stents will soon boast new labels with a revised nine-month expiration date, after the company received US FDA approval to extend the device's shelf life by an additional three months.